GlassScriptPhysician profile
Fady Gabra
NPI 1396277828
$7,027.83
in general payments reported to CMS, 2019-2025
16 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $2,977 · 2023: $497 · 2024: $1,358 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Travel and Lodging: $742 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,726.81 |
| Travel and Lodging | $742.24 |
| Education | $274.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,070.04 | 2022-2025 | Cardiomems, Assurity, Aveir |
| Boston Scientific Corporation | $990.52 | 2021-2024 | Avvigo Guidance System, Watchman Flx, Hornet 10 |
| Philips North America LLC | $846.92 | 2025 | Igt Devices Undivided |
| Shockwave Medical, INC | $716.73 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $467.11 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $220.28 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $168.10 | 2025 | Repatha |
| Medtronic, INC. | $133.07 | 2021 | |
| Biotronik INC. | $129.74 | 2022 | |
| Pfizer INC. | $83.14 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $51.27 | 2024 | Camzyos |
| Irhythm Technologies, INC. | $51.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $39.93 | 2023 | Evkeeza, Praluent |
| Novartis Pharmaceuticals Corporation | $33.09 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.55 | 2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.18 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fady Gabra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.